IFNA1 and Cirrhosis: The EASL clinical practice guideline and the expert’s opinions recommended that HCV-2 patients with cirrhosis and with BMI >30 kg/m2 should receive 24–48 weeks of Peg-IFN plus RBV regardless of RVR17, 28.